Thermo Fisher Scientific Q2 2025: Revenue Rises 3% to $10.85B, GAAP EPS Up 6% to $4.28

Reuters
07/23
Thermo Fisher Scientific <a href="https://laohu8.com/S/QTWO">Q2</a> 2025: Revenue Rises 3% to $10.85B, GAAP EPS Up 6% to $4.28

Thermo Fisher Scientific Inc. has announced its financial results for the second quarter of 2025, showing a 3% increase in revenue, reaching $10.85 billion. The company also reported a 6% rise in GAAP diluted earnings per share $(EPS)$, which amounted to $4.28. The adjusted EPS for the period was $5.36. The company highlighted its strong operational performance, attributing it to the effective management of the macroenvironment and the strength of its PPI Business System. Marc N. Casper, chairman, president, and CEO of Thermo Fisher Scientific, noted the company's success in navigating current market conditions and maintaining its trusted partner status with customers, which has allowed for market share gains. Thermo Fisher Scientific plans to provide updated financial guidance for 2025 during its earnings conference call. The company is committed to delivering on its 2025 commitments and fostering future growth.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Thermo Fisher Scientific Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250722221293) on July 23, 2025, and is solely responsible for the information contained therein.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10